Revvity | PKI - 销售毛利



金融业
股票价格
USD
资产
USD 12.05B
现金及等价物
USD 1.02B
销售成本
USD 312.82M
流动资产
USD 2.3B
流动负债
USD 1.28B
债务
USD 3.35B
股息收益率
0.25
EBIT
USD 126.14M
EBITDA
USD 228.18M
员工
11K
EPS每股收益
USD 1.41
股本和储备
USD 7.18B
销售毛利
USD 416.87M
债务利息支出
USD 22.99M
利息收入
USD 6.3M
贷款资金
USD 2.63B
市值
USD 14.11B
净收入
USD 51.82M
营业费用
USD 603.55M
营业利润
USD 126.14M
普通股股本
USD 111.63M
PE价格收益
36.47
税前利润
USD 187.24M
销售收入
USD 729.68M
销售和管理费用
USD 278.58M
股票
USD 378.5M
贸易债权人
USD 165.74M
应收帐款人
USD 709.18M


销售毛利 更改 日
Agilent USD 990M 44M 2026-03
Align Technology USD 757.43M 20.84M 2026-06
Bio Techne USD 208.29M 17.01M 2026-03
Bio-Rad Laboratories USD 309.4M 35.8M 2026-03
Bruker USD 416M 36.2M 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Charles River Laboratories USD 348.78M 69.47M 2026-06
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Danaher USD 3.61B 20M 2026-06
Dentsply International USD 493M 66M 2026-06
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Illumina USD 770M 49M 2026-06
Intuitive Surgical USD 2.02B 193.4M 2026-06
IQVIA Holdings USD 1.44B 368M 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Laboratory Of America USD 1.11B 98.2M 2026-06
Medical Developments International AUD 7.35M 7.37M 2025-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
Mettler Toledo International USD 555.82M 119.62M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
OraSure Technologies USD 11.34M 435K 2025-12
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pacific Biosciences Of California USD 15.74M 601K 2025-12
Pharma Mar EUR 44.87M 5.63M 2026-06
Qiagen NV USD 309.6M 15.67M 2026-03
Quest Diagnostics USD 906M 33M 2026-03
Quidel USD 223.9M 315.7M 2026-06
Repligen USD 110.04M 1.75M 2026-06
Revvity USD 416.87M 29.21M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Thermo Fisher Scientific USD 4.49B 146M 2026-03
Tilray USD 57.47M 10.16M 2025-06
Waters USD 490M 52M 2026-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03